Economic Observation Network Wanfu Biotechnology (300482) has been in a bearish trend in the past 5 days, performing basically on par with the market and staying at the industry average level. In the past 5 days, the main funds have shown a net outflow overall, with a net proportion close to the market average. On October 14th, the main funds showed a net inflow overall, with a net proportion higher than the market average. The margin trading difference accounts for 4.43%.

The market attention of this stock is average, and the overall public opinion is neutral. The frequency of institutional research is relatively low, and the overall research report rating has not changed much. The latest quarterly report disclosed a+0.01% change in the holding ratio of active equity funds in this stock. The company has average profitability, weak growth ability, average operational ability, and average debt paying ability. The current valuation is in the historically low range, at a relatively low level within the industry. The current price to earnings TTM is negative, lower than the industry median, and has been at the 1.9% level for individual stocks in the past 5 years.

The above content is based on publicly available information and does not constitute investment advice.